ArticleScientific reports2025
Assessment of target-enrichment library preparation and next-generation sequencing of paraffin-embedded gastric biopsies for H. pylori diagnosis and evaluation of virulome and resistome.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The diagnosis of Helicobacter pylori infection from gastric biopsies requires polymerase chain reaction or culture. However, culture is often unsuccessful due to the bacterial fragility and complex growth requirements. Next-generation sequencing (NGS), performed on primary clinical samples, offers a promising alternative for analysis of the bacterial resistome. In this study, we describe the adaptation of a target-enrichment library preparation and NGS workflow for use on formalin-fixed, paraffin-embedded (FFPE) gastric biopsies to investigate both the H. pylori resistome and virulome. In total, 30 FFPE gastric biopsy samples were analyzed, all derived from patients infected with H. pylori, the majority of whom presented with gastritis or epigastric pain. The Agilent SureSelect XT protocol was modified for implementation on the Magnis automated system, and sequencing was performed using the iSeq 100 platform. RNA probes targeting key genes associated with virulence (e.g., cagA and vacA), antibiotic resistance (e.g., 23S rRNA, 16S rRNA, gyrA, and rpoB), and multilocus sequence typing (MLST) were employed. The resulting sequence data were compared to those obtained from cultured H. pylori strains isolated from the same patients. Mutations in 23S rRNA linked to macrolide resistance, those in the quinolone resistance-determining region of gyrA associated with levofloxacin resistance, and those conferring rifamycin resistance were accurately detected. The MLST profiles generated through this method were consistent with those obtained via Sanger sequencing. Furthermore, the cagA gene, including EPIYA motifs, and vacA genotypes were reliably identified. This target-enrichment technique provides accurate access to the H. pylori resistome and virulome directly from FFPE biopsy specimens, representing a significant technological advancement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.